1. A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third‐generation B‐domain‐deleted recombinant factor VIII. Issue 2 (1st February 2018) Authors: Dubé, E.; Bonnefoy, A.; Merlen, C.; Castilloux, J.‐F.; Cloutier, S.; Demers, C.; Sabapathy, C. A.; St‐Louis, J.; Vezina, C.; Warner, M.; Rivard, G.‐É. Journal: Haemophilia Issue: Volume 24:Issue 2(2018) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗